Chemed Corporation Stock Fair Value – Chemed Corporation to Release Q3 Earnings Report on October 29th
October 23, 2024
🌥️Trending News
Chemed Corporation ($NYSE:CHE) is a publicly traded company that offers healthcare and hospice services in the United States. The company’s stock has been performing well, with a steady increase in value over the past few years. Chemed prides itself on providing high-quality, compassionate care to patients and their families, making it a trusted name in the healthcare industry. On October 29th, Chemed Corporation will release their third quarter earnings report after the market closes. This highly anticipated release will provide investors and analysts with valuable insights into the company’s financial performance and future outlook. Investors will be looking at key metrics such as revenue, earnings per share, and net income to evaluate the company’s financial health. They will also closely examine any changes in these numbers compared to previous quarters and the company’s performance compared to industry peers.
Additionally, analysts will pay attention to any updates on Chemed’s growth strategies, new partnerships or acquisitions, and potential market expansion plans. These factors can impact the company’s long-term growth potential and ultimately affect investors’ decisions. Chemed Corporation has consistently delivered strong financial results, with steady revenue growth and increasing profits year after year. This has helped to build investor confidence and has been reflected in the company’s stock performance. The healthcare industry continues to be a vital sector, with an increasing demand for quality care services. As Chemed focuses on providing exceptional care to patients and their families, the company is well-positioned to continue its positive financial trajectory. With a track record of strong financial performance and a commitment to providing high-quality care, the company is expected to continue its upward trend. Investors should keep a close eye on the results and any updates from the company to make informed decisions about their investments in Chemed Corporation.
Earnings
On October 29th, CHEMED CORPORATION, a leading healthcare and hospice company, will be releasing their third quarter earnings report for 2021. According to the latest earnings report for the fourth quarter of FY2023, which ended on December 31st, 2021, CHEMED CORPORATION recorded a total revenue of 540.98M USD. This trend is expected to continue in the upcoming earnings report, with analysts predicting a total revenue of 585.91M USD for the company.
The release of this earnings report will provide investors, stakeholders, and the general public with valuable insights into CHEMED CORPORATION’s financial health and overall performance. It will also offer an opportunity to assess the company’s growth strategies and potential for future success in the healthcare and hospice industry.
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Chemed Corporation. More…
| Total Revenues | Net Income | Net Margin |
| 2.26k | 272.51 | 12.0% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Chemed Corporation. More…
| Operations | Investing | Financing |
| 330.3 | -60.64 | -79.83 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Chemed Corporation. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 1.67k | 560.22 | 73.82 |
Key Ratios Snapshot
Some of the financial key ratios for Chemed Corporation are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 2.9% | -4.8% | 15.6% |
| FCF Margin | ROE | ROA |
| 12.1% | 20.8% | 13.2% |
Market Price
On Tuesday, October 29th, healthcare and hospice services provider CHEMED CORPORATION will be releasing its third quarter earnings report. This highly-anticipated report will provide valuable insights into the company’s financial performance during the months of July, August, and September. Investors and analysts alike will be paying close attention to this release, as CHEMED CORPORATION’s stock has been performing well in recent months. On Tuesday, the stock opened at $597.08 and closed at $593.82, showing a slight decrease of 1.13% from its previous closing price of $600.58. This dip in stock price could potentially be attributed to market fluctuations and uncertainty surrounding the company’s upcoming earnings report. One of the key factors that will be closely monitored in the earnings report is CHEMED CORPORATION’s revenue growth. Analysts will be looking to see if this growth trend has continued in the third quarter.
Additionally, profitability metrics such as earnings per share (EPS) and operating margin will also be examined to gauge the company’s financial health. Investors will also be interested in hearing updates on any strategic initiatives or expansion plans that CHEMED CORPORATION may have in the works. In recent years, the company has made several acquisitions and partnerships to further strengthen its position in the healthcare industry. Any announcements related to these efforts could have an impact on the stock price. The company’s financial performance, particularly in terms of revenue growth and profitability, will be closely scrutinized by investors and analysts. Any updates on strategic initiatives could also influence the market’s perception of the company’s future prospects. Stay tuned for the highly-anticipated release of CHEMED CORPORATION’s earnings report. Live Quote…
Analysis – Chemed Corporation Stock Fair Value
After conducting a thorough analysis of CHEMED CORPORATION, I have determined that the company has strong fundamentals. The company has a solid financial standing, with a strong balance sheet and a history of consistent earnings growth. Additionally, CHEMED CORPORATION has a diverse portfolio of healthcare services, including hospice care and home healthcare, which provides stability and resilience to the business. Based on our proprietary Valuation Line, the fair value of CHEMED CORPORATION’s share is estimated to be around $544.3. This calculation takes into consideration various factors such as the company’s financial performance, industry trends, and market conditions. Therefore, at its current price of $593.82, CHEMED CORPORATION’s stock is overvalued by 9.1%. Investors should keep in mind that overvaluation does not necessarily mean that the stock is a bad investment. However, it may indicate that the stock has limited room for further growth and may be at risk for a potential correction. Therefore, it is important to carefully consider all aspects of the company before making an investment decision. In conclusion, while CHEMED CORPORATION has strong fundamentals and a diverse portfolio of healthcare services, its current stock price appears to be overvalued. Investors should carefully weigh the potential risks and returns before deciding to invest in the company. More…
Peers
The competition between Chemed Corp and its competitors is fierce. Chemed Corp is the largest provider of hospice care in the United States, and its competitors are Brookdale Senior Living Inc, Encompass Health Corp, and Pennant Group Inc. All of these companies are vying for a share of the $15 billion hospice market. Chemed Corp has a lot of experience in the hospice industry, and its competitors are trying to catch up.
– Brookdale Senior Living Inc ($NYSE:BKD)
Brookdale Senior Living Inc is a company that owns and operates senior living communities. As of 2022, the company had a market cap of 837.09M and a ROE of 10.52%. The company offers a variety of services for seniors, including independent living, assisted living, memory care, and skilled nursing.
– Encompass Health Corp ($NYSE:EHC)
Encompass Health Corporation is a provider of rehabilitation and wellness services. The company operates through two segments: Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides rehabilitation services on an inpatient basis to patients recovering from illnesses and injuries. The Home Health and Hospice segment provides home health services to patients recovering from illnesses and injuries. Encompass Health Corporation was founded in 1985 and is headquartered in Birmingham, Alabama.
– Pennant Group Inc ($NASDAQ:PNTG)
The Pennant Group, Inc. is a provider of healthcare services for senior living communities and post-acute care centers in the United States. The company operates through three segments: Senior Living, Home Health, and Hospice. The Senior Living segment offers a range of services, including skilled nursing, assisted living, independent living, and memory care services. The Home Health segment provides home health services, such as skilled nursing, physical therapy, occupational therapy, and speech therapy. The Hospice segment offers hospice services, including nursing care, social work services, chaplain services, and bereavement counseling.
Summary
Chemed Corporation is set to release its quarterly earnings report on October 29th. This provides investors with an opportunity to analyze the company’s financial performance and make investment decisions based on the results. Key metrics to watch include revenue growth, earnings per share, and any updated guidance for the future.
Investors will also be paying attention to any updates on the company’s hospice and plumbing segments, as well as any potential impact from healthcare policy changes. Overall, a positive earnings report could signal a strong financial outlook for Chemed Corporation and potentially attract new investors.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
